180 related articles for article (PubMed ID: 22771905)
1. Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF.
Zhang J; Zhao H; Chen J; Xia B; Jin Y; Wei W; Shen J; Huang Y
FEBS Lett; 2012 Sep; 586(19):3255-62. PubMed ID: 22771905
[TBL] [Abstract][Full Text] [Related]
2. miRNA-340 inhibits osteoclast differentiation via repression of MITF.
Zhao H; Zhang J; Shao H; Liu J; Jin M; Chen J; Huang Y
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607030
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
[TBL] [Abstract][Full Text] [Related]
4. Suppressors of cytokine signaling-1 and -3 regulate osteoclastogenesis in the presence of inflammatory cytokines.
Ohishi M; Matsumura Y; Aki D; Mashima R; Taniguchi K; Kobayashi T; Kukita T; Iwamoto Y; Yoshimura A
J Immunol; 2005 Mar; 174(5):3024-31. PubMed ID: 15728516
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-17/20a inhibits glucocorticoid-induced osteoclast differentiation and function through targeting RANKL expression in osteoblast cells.
Shi C; Qi J; Huang P; Jiang M; Zhou Q; Zhou H; Kang H; Qian N; Yang Q; Guo L; Deng L
Bone; 2014 Nov; 68():67-75. PubMed ID: 25138550
[TBL] [Abstract][Full Text] [Related]
6. NF-κB promotes osteoclast differentiation by overexpressing MITF via down regulating microRNA-1276 expression.
Zhang Y; Ma C; Liu C; Wu W
Life Sci; 2020 Oct; 258():118093. PubMed ID: 32673666
[TBL] [Abstract][Full Text] [Related]
7. MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice.
Kim HN; Lee JH; Jin WJ; Ko S; Jung K; Ha H; Lee ZH
Eur J Pharmacol; 2012 Sep; 691(1-3):69-76. PubMed ID: 22846626
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
Asai K; Funaba M; Murakami M
Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
[TBL] [Abstract][Full Text] [Related]
9. HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors.
van der Kraan AG; Chai RC; Singh PP; Lang BJ; Xu J; Gillespie MT; Price JT; Quinn JM
Biochem J; 2013 Apr; 451(2):235-44. PubMed ID: 23379601
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.
He L; Lee J; Jang JH; Lee SH; Nan MH; Oh BC; Lee SG; Kim HH; Soung NK; Ahn JS; Kim BY
Bone; 2012 Jun; 50(6):1207-13. PubMed ID: 22484180
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
[TBL] [Abstract][Full Text] [Related]
12. Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB.
Ripoll VM; Meadows NA; Raggatt LJ; Chang MK; Pettit AR; Cassady AI; Hume DA
Gene; 2008 Apr; 413(1-2):32-41. PubMed ID: 18313864
[TBL] [Abstract][Full Text] [Related]
13. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta.
Takayanagi H; Kim S; Matsuo K; Suzuki H; Suzuki T; Sato K; Yokochi T; Oda H; Nakamura K; Ida N; Wagner EF; Taniguchi T
Nature; 2002 Apr; 416(6882):744-9. PubMed ID: 11961557
[TBL] [Abstract][Full Text] [Related]
14. Deletion of histone deacetylase 7 in osteoclasts decreases bone mass in mice by interactions with MITF.
Stemig M; Astelford K; Emery A; Cho JJ; Allen B; Huang TH; Gopalakrishnan R; Mansky KC; Jensen ED
PLoS One; 2015; 10(4):e0123843. PubMed ID: 25875108
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.
Chang EJ; Kim HJ; Ha J; Kim HJ; Ryu J; Park KH; Kim UH; Lee ZH; Kim HM; Fisher DE; Kim HH
J Cell Sci; 2007 Jan; 120(Pt 1):166-76. PubMed ID: 17164294
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-beta-induced inhibitory signaling.
Lee Y; Hyung SW; Jung HJ; Kim HJ; Staerk J; Constantinescu SN; Chang EJ; Lee ZH; Lee SW; Kim HH
Blood; 2008 Jan; 111(2):885-93. PubMed ID: 17928529
[TBL] [Abstract][Full Text] [Related]
17. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
18. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
[TBL] [Abstract][Full Text] [Related]
19. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.
Bai S; Kitaura H; Zhao H; Chen J; Müller JM; Schüle R; Darnay B; Novack DV; Ross FP; Teitelbaum SL
J Clin Invest; 2005 Oct; 115(10):2742-51. PubMed ID: 16184196
[TBL] [Abstract][Full Text] [Related]
20. Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL).
Ang ES; Zhang P; Steer JH; Tan JW; Yip K; Zheng MH; Joyce DA; Xu J
J Cell Physiol; 2007 Sep; 212(3):787-95. PubMed ID: 17477372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]